Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1931 Quality of Life, Anxiety and Depression in Patients with NEN after Surgery

Introduction: Less is known about quality of life and psychiatric disorders in surgical cohort of NEN patients (pts.).

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Begum N

Authors: Begum N, Hunold H, Waldmann A, Bürk C, Keck T,

Keywords: surgery, QoL, anxiety, depression,

#1868 Study Protocol: Prospective, Randomized Controlled Trial on the Effect of Primary Resection in Advanced Metastatic NEN of Pancreas and Midgut (PRESNENAS)

Introduction: The role of Primary Tumor resection in advanced metastatic NEN is discussed controversely.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Begum N

Authors: Begum N, Pavel M, Goretzki P, Vonthein R,

Keywords: Prospective Randomized, Controlled Trial, Surgery, Role of Primary Resection,

#1237 Risk Factors for Survival from Neuroendocrine Neoplasia with Unknown Primary Tumor Site

Introduction: Neuroendocrine neoplasia (NEN) with unknown primary site (NEN-CUP) may have a poor prognosis. We evaluated the clinical presentation, therapy, outcome, and risk factors for adverse outcomes in patients with NEN-CUP.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Begum N

Authors: Begum N, Wellner U, Thorns C, Hoffmann M, Bürk C,

Keywords: outcome, NEN-CUP, surgery, survival,

#1201 Results of Sunitinib Treatment of Advanced Neuroendocrine Neoplasms: “Real-life” Outcome Data from the German NET-Register

Introduction: Among modern treatments (Tx) for neuroendocrine neoplasms (NEN) sunitinib (SUN) has impacted Tx of primarily pancreatic NEN (pNEN).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Bacher M, Maasberg S, Fottner C, Begum N, Quietzsch D,

Keywords: sunitinib, outcome,

#1200 Clinical Outcome of Everolimus Treatment of Advanced Neuroendocrine Neoplasms: “Real-life” Data from the German NET-Register

Introduction: Everolimus (EVE) has importantly impacted the treatment (Tx) of mostly pancreatic NEN.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Pape U

Authors: Pape U, Bacher M, Fottner C, Lahner H, Begum N,

Keywords: everolimus, outcome,